These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36638645)

  • 1. Evaluation of the goat cellular immune response to rBtuB-Hia-FlgK peptides from Brucella melitensis.
    De la Rosa-Ramos MA; Arellano-Reynoso B; Hernández-Badillo E; Guerra-Infante FM; Mancilla-Herrera I; Chaki SP; Ficht TA; Suárez-Güemes F
    Comp Immunol Microbiol Infect Dis; 2023 Mar; 94():101944. PubMed ID: 36638645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
    Higgins JL; Bowen RA; Gonzalez-Juarrero M
    Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
    Díaz-Aparicio E; Hernández L; Suárez-Güemes F
    Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live mucosal vaccination stimulates potent protection
    Goodwin ZI; Yang X; Hoffman C; Pascual DW
    Front Immunol; 2022; 13():995327. PubMed ID: 36263034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
    Clapp B; Yang X; Thornburg T; Walters N; Pascual DW
    Immunol Cell Biol; 2016 May; 94(5):496-508. PubMed ID: 26752510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev. 1.
    al-Khalaf SA; Mohamad BT; Nicoletti P
    Trop Anim Health Prod; 1992 Feb; 24(1):45-9. PubMed ID: 1306918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats.
    Díaz-Aparicio E; Marín C; Alonso-Urmeneta B; Aragón V; Pérez-Ortiz S; Pardo M; Blasco JM; Díaz R; Moriyón I
    J Clin Microbiol; 1994 May; 32(5):1159-65. PubMed ID: 8051240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
    Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MΔvjbR strain in goats.
    Castaño-Zubieta MR; Rossetti CA; García-González DG; Maurizio E; Hensel ME; Rice-Ficht AC; Ficht TA; Arenas-Gamboa ÁM
    Vaccine; 2021 Jan; 39(3):617-625. PubMed ID: 33328142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.
    Sancho P; Tejedor C; Sidhu-Muñoz RS; Fernández-Lago L; Vizcaíno N
    Vet Res; 2014 Jun; 45(1):61. PubMed ID: 24898325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
    Blasco JM
    Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.